JPS6225148B2 - - Google Patents

Info

Publication number
JPS6225148B2
JPS6225148B2 JP52124129A JP12412977A JPS6225148B2 JP S6225148 B2 JPS6225148 B2 JP S6225148B2 JP 52124129 A JP52124129 A JP 52124129A JP 12412977 A JP12412977 A JP 12412977A JP S6225148 B2 JPS6225148 B2 JP S6225148B2
Authority
JP
Japan
Prior art keywords
group
stirred
mol
solution
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP52124129A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5350167A (en
Inventor
Eru Howaito Junia Rarufu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NOOITSUCHI IITON PHARM Inc
Original Assignee
NOOITSUCHI IITON PHARM Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NOOITSUCHI IITON PHARM Inc filed Critical NOOITSUCHI IITON PHARM Inc
Publication of JPS5350167A publication Critical patent/JPS5350167A/ja
Publication of JPS6225148B2 publication Critical patent/JPS6225148B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
JP12412977A 1976-10-18 1977-10-18 11***55*substituted**22oxazolyl*methlene*amino** 2*44imidalizinedione and its preparation Granted JPS5350167A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/733,296 US4049650A (en) 1976-10-18 1976-10-18 1-[[[5-(Substituted phenyl)-2-oxazolyl]methylene]amino]-2,4-imidazolidinediones

Publications (2)

Publication Number Publication Date
JPS5350167A JPS5350167A (en) 1978-05-08
JPS6225148B2 true JPS6225148B2 (2) 1987-06-01

Family

ID=24947035

Family Applications (1)

Application Number Title Priority Date Filing Date
JP12412977A Granted JPS5350167A (en) 1976-10-18 1977-10-18 11***55*substituted**22oxazolyl*methlene*amino** 2*44imidalizinedione and its preparation

Country Status (14)

Country Link
US (1) US4049650A (2)
JP (1) JPS5350167A (2)
AU (1) AU505351B2 (2)
BE (1) BE859819A (2)
CA (1) CA1084510A (2)
CH (1) CH629800A5 (2)
DE (1) DE2746550A1 (2)
ES (1) ES463297A1 (2)
FR (1) FR2367763A1 (2)
GB (1) GB1530770A (2)
MX (1) MX5011E (2)
NL (1) NL7711416A (2)
SE (1) SE435382B (2)
ZA (1) ZA775228B (2)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2657559A1 (de) * 1976-12-18 1978-06-22 Bayer Ag Dioxopiperazinderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel und als zwischenprodukte fuer beta-lactamantibiotika
US4128711A (en) * 1977-10-06 1978-12-05 Morton-Norwich Products, Inc. 1-[[1H-Pyrrol-2-ylmethylene]amino]-2,4-imidazolidinedione
US4822629A (en) * 1986-12-12 1989-04-18 Norwich Eaton Pharmaceuticals, Inc. Azumolene dosage form
US4861790A (en) * 1987-10-28 1989-08-29 Norwich Eaton Pharmaceuticals, Inc. Use of azumolene for the treatment of malignant hyperthermia
WO2007145203A1 (ja) * 2006-06-13 2007-12-21 Daiichi Fine Chemical Co., Ltd. 光学活性２－アミノ－１－（４－フルオロフェニル）エタノール
EP2484359B1 (en) 2009-09-30 2018-07-25 Shiseido Company, Ltd. Heparanase activity inhibitor
HUP1300720A2 (hu) * 2013-12-12 2015-06-29 Univ Szegedi Gyógyászati készítmények sebgyógyulás elõsegítésére

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3415821A (en) * 1965-09-07 1968-12-10 Norwich Pharma Co 1-(5-substituted)furfurylideneamino hydantoins and imidazolidinones
DE2106298A1 (2) * 1971-02-10 1972-10-12
US3803136A (en) * 1972-08-23 1974-04-09 Morton Norwich Products Inc 5-hydroxy-1-((5-(substituted phenyl)furfurylidene)amino)hydrantoins
US3843636A (en) * 1974-01-25 1974-10-22 Morton Norwich Products Inc 1-(5-(p-methoxyphenyl)furfurylidene)amino)hydantoin
US4001222A (en) * 1975-10-14 1977-01-04 Morton-Norwich Products, Inc. 3-(Aminoacyl)-1-{[5-(substituted phenyl)furfurylidene]amino}hydantoins and process for their preparation thereof

Also Published As

Publication number Publication date
MX5011E (es) 1983-02-16
FR2367763A1 (fr) 1978-05-12
ES463297A1 (es) 1978-11-16
SE435382B (sv) 1984-09-24
CH629800A5 (de) 1982-05-14
AU2803677A (en) 1979-02-22
US4049650A (en) 1977-09-20
DE2746550A1 (de) 1978-04-20
AU505351B2 (en) 1979-11-15
FR2367763B1 (2) 1980-06-27
SE7710086L (sv) 1978-04-19
CA1084510A (en) 1980-08-26
BE859819A (fr) 1978-04-17
DE2746550C2 (2) 1987-10-15
JPS5350167A (en) 1978-05-08
NL7711416A (nl) 1978-04-20
ZA775228B (en) 1979-04-25
GB1530770A (en) 1978-11-01

Similar Documents

Publication Publication Date Title
Bentiss et al. A new synthesis of symmetrical 2, 5‐disubstituted 1, 3, 4‐oxadiazoles
ES2331220B1 (es) Nuevos compuestos como antagonistas de los receptores a1 de adenosina.
JP2008511601A5 (2)
PT87552B (pt) Processo para a preparacao de novos derivados de tetrazol utilizaveis como compostos intermedios na preparacao de agentes antihipertensivos
Norris 5-Trifluoromethyltetrazole and its derivatives
CY1446A (en) Chemical compounds derived from cyclobutene
JPS6225148B2 (2)
EP0000128A1 (de) Sulfamoyl-Arylketone und Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
PL190265B1 (pl) Sposób wytwarzania związków 2-arylo-3-arylopirydynowych
JPH07103127B2 (ja) チエノートリアゾロ―ジアゼピン誘導体、その製造法及びそれを含有する抗喘息、抗アレルギー剤
JPH026354B2 (2)
JP2015523985A (ja) ジアリールヨードニウム塩を製造するための方法及び反応剤
SE434944B (sv) 5-(klorofenyl)-6h-1,3,4-tiadiazin-2-aminer
JP3045354B2 (ja) チオキサンテノン類およびその抗腫瘍剤
US3676463A (en) Oxobenzofuran carboxamides
FI82249B (fi) Foerfarande foer framstaellning av nya pyridinderivat.
JP2006500409A5 (2)
DE60000790T2 (de) [(2-substituierte-5-[3-thienyl)-benzyl]-[2-([2-isopropoxy-5-fluoro]-phenoxy)-ethyl]-amine, verfahren zu ihrer herstellung und ihre verwendung als medikamente
PT869952E (pt) Derivados de 5-naftalen-1-il-1,3-dioxanos processo para a sua preparacao e sua aplicacao em terapeutica
CA1125297A (en) Benzene and thiophene-carbothioic acid 2-aminoalkyl ester acid salts
CN103570584B (zh) 一种取代苯甲脒类化合物的合成方法
IE32360L (en) Thioimidates
WO2005060692A2 (en) Biphenyl compounds and methods
Klepo et al. Studies in the furan series. 22. N-Arylfurfuryl-and 5-methylfurfurylamines and their N-allyl derivatives
JPS5813587A (ja) オキサゾ−ル誘導体